ArticlePharmaceutics2022

Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations.

Hafsa Hafsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.